A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

Authors/Creators

• Santoro, A.
• Gebbia, V.
• Pressiani, T.
• Testa, A.
• Personeni, N.
• Arrivas Bajardi, E.
• Foa, P.
• Buonadonna, A.
• Bencardino, K.
• Barone, C.
• et al. Show all 18 authors